as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.42%
Downside
3.25%
Upside
52 Week's Low
52 Week's High
16.95%
Downside
200.10%
Upside
Check Nurix Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$771.1M
EPS (TTM)
-3.2252
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.76
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-259.4M
Revenue (TTM)
83.7M
Profit Margin
-292.50%
Return On Equity TTM
3961000.00%
Track how Nurix Therapeutics Inc P/E has moved over time to understand its valuation trends.
Nurix Therapeutics Inc in the last 5 years
Lowest (-13.42x)
February 28, 2021
Today (-9.76x)
October 18, 2025
Industry (-0.32x)
October 18, 2025
Highest (-2.59x)
November 30, 2023
Today’s Price to Earnings Ratio: -9.76x
Compare market cap, revenue, PE, and other key metrics of Nurix Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $771.1M | -61.49% | -9.76 | -292.50% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Nurix Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nurix Therapeutics Inc investment value today
Current value as on today
₹44,116
Returns
Returns from Nurix Therapeutics Inc Stock
Dollar Returns*
₹4,794 (+4.79%)
Based on 17 analysts
88.24%
Buy
11.76%
Hold
0.00%
Sell
Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Nurix Therapeutics Inc. Average target price of $29.94
Get share price movements and forecasts by analysts on Nurix Therapeutics Inc.
What analysts predicted
67.1%UPSIDE
Target Price
$29.94
Current Price
$9.85
Analyzed by
17 Analysts
Target
$29.94
Nurix Therapeutics Inc target price $29.94, a slight upside of 67.1% compared to current price of $9.85. According to 17 analysts rating.
Search interest for Nurix Therapeutics Inc Stock has increased by 230% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:230% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 123.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.9% return, outperforming this stock by 161.3%
Revenue Fall
Revenue is down for the last 2 quarters, 44.05M → 7.89M (in $), with an average decrease of 82.1% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -43.46M → -86.42M (in $), with an average decrease of 98.8% per quarter
Price Dip
In the last 1 year, NRIX stock has moved down by -60.7%
Organisation | Nurix Therapeutics Inc |
Headquarters | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Industry | Health Technology |
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Arthur Weiss M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
Dr. Jason Kantor Ph.D. | Chief Business Officer |
Mr. Christopher B. Phelps Ph.D. | Senior VP & Head of Early Drug Discovery |
Dr. Gwenn M. Hansen Ph.D. | Chief Scientific Officer |
Mr. Johannes Van Houte | Chief Financial Officer |
Dr. Christine Ring J.D., Ph.D. | Chief Legal Officer, Secretary & Chief Compliance Officer |
Dr. John Kuriyan Ph.D. | Founder & Member of Scientific Advisory Board |
Rita Kwong | Senior Accounting Manager |
Dr. Pasit Phiasivongsa Ph.D. | Chief Technical Officer |
Dr. Arthur T. Sands M.D., Ph.D. | CEO, President & Director |
Nurix Therapeutics Inc share price today is $9.85 as on at the close of the market. Nurix Therapeutics Inc share today touched a day high of $10.17 and a low of $9.71.
Nurix Therapeutics Inc share touched a 52 week high of $29.56 on and a 52 week low of $8.18 on . Nurix Therapeutics Inc stock price today i.e. is closed at $9.85,which is 66.68% down from its 52 week high and 20.42% up from its 52 week low.
Nurix Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Nurix Therapeutics Inc (NRIX) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Nurix Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nurix Therapeutics Inc share’s latest price of $9.85 as on October 18, 2025 at 1:29 am IST, you will get 1.0152 shares of Nurix Therapeutics Inc. Learn more about
fractional shares .
Nurix Therapeutics Inc stock has given -61.49% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?